Genetic bases of comorbidity between mood disorders and migraine: Possible role of serotonin transporter gene

Elena Marino, Bongiorno Fanny, Cristina Lorenzi, Adele Pirovano, Linda Franchini, Cristina Colombo, Placido Bramanti, Enrico Smeraldi

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Migraine is a common neurological disease in the population and the most associated headache with mood disorder. Although the relationship between migraine and depression is well known, the reverse correlation between depression and migraine was observed but not well understood. The tight relationship between the two disturbances is also suggested by the efficacy of antidepressants for migraine treatment. Starting from these observations, we can presume that both migraine and depression have overlapping biological bases. The main target of antidepressant treatments belonging to the serotonin selective reuptake inhibitors (SSRI) type is the serotonin transporter (SERT); a well-studied polymorphic variant, in the promoter region of the gene (SERTPR), has been demonstrated to influence the availability of serotonin in the synaptic cleft. So, our group studied the possible role of the SERT as a risk factor, both for migraine and mood disorders, in a sample of 96 patients affected by both pathologies.

Original languageEnglish
Pages (from-to)387-391
Number of pages5
JournalNeurological Sciences
Volume31
Issue number3
DOIs
Publication statusPublished - Jun 2010

Fingerprint

Serotonin Plasma Membrane Transport Proteins
Migraine Disorders
Mood Disorders
Comorbidity
Genes
Depression
Antidepressive Agents
Serotonin Uptake Inhibitors
Genetic Promoter Regions
Headache
Serotonin
Pathology
Therapeutics
Population

Keywords

  • Genetics
  • Migraine
  • Mood disorders
  • Serotonin transporter

ASJC Scopus subject areas

  • Medicine(all)
  • Dermatology
  • Clinical Neurology
  • Psychiatry and Mental health

Cite this

Genetic bases of comorbidity between mood disorders and migraine : Possible role of serotonin transporter gene. / Marino, Elena; Fanny, Bongiorno; Lorenzi, Cristina; Pirovano, Adele; Franchini, Linda; Colombo, Cristina; Bramanti, Placido; Smeraldi, Enrico.

In: Neurological Sciences, Vol. 31, No. 3, 06.2010, p. 387-391.

Research output: Contribution to journalArticle

Marino, Elena ; Fanny, Bongiorno ; Lorenzi, Cristina ; Pirovano, Adele ; Franchini, Linda ; Colombo, Cristina ; Bramanti, Placido ; Smeraldi, Enrico. / Genetic bases of comorbidity between mood disorders and migraine : Possible role of serotonin transporter gene. In: Neurological Sciences. 2010 ; Vol. 31, No. 3. pp. 387-391.
@article{68e602d3afd246648758ac6e45127e5e,
title = "Genetic bases of comorbidity between mood disorders and migraine: Possible role of serotonin transporter gene",
abstract = "Migraine is a common neurological disease in the population and the most associated headache with mood disorder. Although the relationship between migraine and depression is well known, the reverse correlation between depression and migraine was observed but not well understood. The tight relationship between the two disturbances is also suggested by the efficacy of antidepressants for migraine treatment. Starting from these observations, we can presume that both migraine and depression have overlapping biological bases. The main target of antidepressant treatments belonging to the serotonin selective reuptake inhibitors (SSRI) type is the serotonin transporter (SERT); a well-studied polymorphic variant, in the promoter region of the gene (SERTPR), has been demonstrated to influence the availability of serotonin in the synaptic cleft. So, our group studied the possible role of the SERT as a risk factor, both for migraine and mood disorders, in a sample of 96 patients affected by both pathologies.",
keywords = "Genetics, Migraine, Mood disorders, Serotonin transporter",
author = "Elena Marino and Bongiorno Fanny and Cristina Lorenzi and Adele Pirovano and Linda Franchini and Cristina Colombo and Placido Bramanti and Enrico Smeraldi",
year = "2010",
month = "6",
doi = "10.1007/s10072-009-0183-y",
language = "English",
volume = "31",
pages = "387--391",
journal = "Neurological Sciences",
issn = "1590-1874",
publisher = "Springer-Verlag Italia s.r.l.",
number = "3",

}

TY - JOUR

T1 - Genetic bases of comorbidity between mood disorders and migraine

T2 - Possible role of serotonin transporter gene

AU - Marino, Elena

AU - Fanny, Bongiorno

AU - Lorenzi, Cristina

AU - Pirovano, Adele

AU - Franchini, Linda

AU - Colombo, Cristina

AU - Bramanti, Placido

AU - Smeraldi, Enrico

PY - 2010/6

Y1 - 2010/6

N2 - Migraine is a common neurological disease in the population and the most associated headache with mood disorder. Although the relationship between migraine and depression is well known, the reverse correlation between depression and migraine was observed but not well understood. The tight relationship between the two disturbances is also suggested by the efficacy of antidepressants for migraine treatment. Starting from these observations, we can presume that both migraine and depression have overlapping biological bases. The main target of antidepressant treatments belonging to the serotonin selective reuptake inhibitors (SSRI) type is the serotonin transporter (SERT); a well-studied polymorphic variant, in the promoter region of the gene (SERTPR), has been demonstrated to influence the availability of serotonin in the synaptic cleft. So, our group studied the possible role of the SERT as a risk factor, both for migraine and mood disorders, in a sample of 96 patients affected by both pathologies.

AB - Migraine is a common neurological disease in the population and the most associated headache with mood disorder. Although the relationship between migraine and depression is well known, the reverse correlation between depression and migraine was observed but not well understood. The tight relationship between the two disturbances is also suggested by the efficacy of antidepressants for migraine treatment. Starting from these observations, we can presume that both migraine and depression have overlapping biological bases. The main target of antidepressant treatments belonging to the serotonin selective reuptake inhibitors (SSRI) type is the serotonin transporter (SERT); a well-studied polymorphic variant, in the promoter region of the gene (SERTPR), has been demonstrated to influence the availability of serotonin in the synaptic cleft. So, our group studied the possible role of the SERT as a risk factor, both for migraine and mood disorders, in a sample of 96 patients affected by both pathologies.

KW - Genetics

KW - Migraine

KW - Mood disorders

KW - Serotonin transporter

UR - http://www.scopus.com/inward/record.url?scp=77955891231&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955891231&partnerID=8YFLogxK

U2 - 10.1007/s10072-009-0183-y

DO - 10.1007/s10072-009-0183-y

M3 - Article

C2 - 19936882

AN - SCOPUS:77955891231

VL - 31

SP - 387

EP - 391

JO - Neurological Sciences

JF - Neurological Sciences

SN - 1590-1874

IS - 3

ER -